Methylpiperazine

Methylpiperazine

SCHEMBL6016376

CN1CCN(c2ncc(C(=O)O)c(-c3ccccc3F)n2)CC1.CN1CCNCC1

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 7/20 0.46
MAPK1 P28482 4/20 0.46
KMT2A Q03164 3/20 0.46
MAPT P10636 1/20 0.46
TACR1 P25103 2/20 0.45
ALDH1A1 P00352 13/20 0.43
HSD17B10 Q99714 13/20 0.43
CYP1A2 P05177 12/20 0.43
CASP1 P29466 9/20 0.43
HIF1A Q16665 9/20 0.43
CASP7 P55210 8/20 0.43
CYP2C19 P33261 5/20 0.43
GLA P06280 4/20 0.43
CYP2C9 P11712 4/20 0.43
HPGD P15428 3/20 0.43
CLK4 Q9HAZ1 3/20 0.43
USP2 O75604 9/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
HTR3A P46098 1/20 0.41
HRH4 Q9H3N8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4129695 0.94 TSHR (0.51) TSHRMAPK1KMT2AMAPTTACR1
SCHEMBL6016368 0.92 ALDH1A1 (0.45) TSHRMAPK1KMT2AALDH1A1HSD17B10
Methylpiperazine SCHEMBL6016369 0.89 TACR1 (0.54) TSHRMAPK1KMT2AMAPTTACR1
Methylpiperazine SCHEMBL6016601 0.88 HRH4 (0.44) TSHRMAPK1KMT2AMAPTTACR1
Methylpiperazine SCHEMBL6016457 0.88 TACR1 (0.43) TSHRMAPK1KMT2AMAPTTACR1
Methylpiperazine SCHEMBL6016296 0.87 TACR1 (0.43) TSHRKMT2ATACR1ALDH1A1HSD17B10
Methylpiperazine SCHEMBL6016489 0.86 TACR1 (0.44) TSHRKMT2AMAPTTACR1ALDH1A1
Methylpiperazine SCHEMBL6016447 0.84 TACR1 (0.46) TSHRMAPK1KMT2AMAPTTACR1
Methylpiperazine SCHEMBL6016623 0.83 ALDH1A1 (0.48) TSHRMAPK1ALDH1A1HSD17B10CYP1A2
Methylpiperazine SCHEMBL6016589 0.82 TACR1 (0.40) TSHRMAPK1TACR1ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1187815-B1 4-PHENYL-PYRIMIDINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2006-02-08 EP disclosed
EP-1187815-A1 4-PHENYL-PYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2002-03-20 EP disclosed
US-6274588-B1 NEUROKININ OR SUBSTANCE P ANTAGONISTS; CENTRAL NERVOUS SYSTEM AND PSYCHOLOGICAL DISORDES; ANTIDEPRESSANTS, ANXIOLYTIC AGENTS HOFFMANN-LA ROCHE INC. 2001-08-14 US disclosed
WO-2000073279-A1 4-PHENYL-PYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2000-12-07 WO disclosed